Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

An extension of North Platte’s first approved microTIF project also appears on the agenda for Tuesday's 5:30 p.m. City Council meeting in the City Hall council chamber.

Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 First Quarter Conference Call. My name is Clint ...

"The initiative reflects our continuous efforts." Supermarket to roll out major change at 77 locations nationwide: 'We're excited for our customers' first appeared on The Cool Down.

For more information, please contact your banking representative directly or visit the Achieve Life Sciences Investor ...

Research and development expenses were $12.6 million for the second quarter of fiscal 2025, compared with $12.0 million for the same period a year ago, with the increase primarily attributable to ...

U.S. Foods Holding Corp ( NYSE: USFD) Q4 2024 Earnings Conference Call February 13, 2025 9:00 AM ET Mike Neese - Senior Vice President, Investor Relations Dave Flitman - Chief Executive Officer Dirk ...

FDA published a final version of its guidance document, “Communications From Firms to Health Care Providers Regarding ...

Acoramidis is the first and only approved ATTR-CM treatment in the U.S. and EU with a label specifying near-complete stabilization (≥90%) Relative increases in serum TTR concentrations resulting from ...

Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...

Lead singer Lane Moore discusses holding back new music for five years and how Valentine's Day became the perfect release ...

If TVA lays off employees to cut operational costs, it won't be because Elon Musk told it to, the utility's CEO said.